Revolka

  • about us
  • business
  • technology
  • case studies
  • pipeline
  • investors
  • news
  • contact
  • jp
  • en
    • about us
    • investors
    • faq
    • contact
    • business
    • aiProtein®
    • RevoAb®
    • results
    • pipeline
    • news

contact Let's explore new
possibilities together.

  1. top
  2. News
  3. Our advertisement feature was published in the online version of Nature

2022.10.13

  • news
  • techinfo

Our advertisement feature was published in the online version of Nature

Our advertisement feature was published in the online version of Nature, a weekly international journal publishing the finest peer-reviewed research in science and technology.

https://www.nature.com/articles/d42473-022-00271-2

  • Previous Article
  • Next Article
  • Back to List

Related Articles

  • 2026.06.19

    • collab
    • news

    [Notice] Updates on Case Study Outcomes and Track Record Summary

  • 2026.06.12

    • news

    RevolKa Director & CSO Prof. Mitsuo Umetsu (Tohoku-Univ.) and Team Announce New AI-Driven Method toAccelerate Discovery of Highly Functional Antibodies

  • 2025.10.16

    • event

    Poster presentation at “Antibody engineering & therapeutics Asia”

News List

contact Let's explore new
possibilities together.
From solving protein design challenges to joint research,
RevolKa's aiProtein® technology accelerates your business.
Feel free to contact us for a consultation.
Our expert team will propose the optimal solution.
  • Corporate Information

    • about us
    • investors
    • faq
    • contact
  • Business &
    Technology

    • business
    • aiProtein®
    • RevoAb®
  • Information &
    Case Studies

    • case studies
    • pipeline
    • news
Revolka

ページトップへ

  • privacy policy
  • legal notice
  • Cookie Settings

© 2025 RevolKa Ltd. All Rights Reserved.